Shared care follow-up after chemotherapy for testicular cancer
Completed
- Conditions
- Testicular cancer100822061001842410038597
- Registration Number
- NL-OMON35515
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 245
Inclusion Criteria
* Patients with disseminated testicular cancer in complete remission after chemotherapy with or without adjunctive surgery and in active follow-up
* Age 18 years or older;
* Started with chemotherapy after January 1st 2003;
* Written informed consent.
Exclusion Criteria
* Mental disability.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint of this study is a safely executed follow-up within the<br /><br>survivorship care plan according to the pre-specified guidelines. The safety of<br /><br>the SCP will be evaluated by the number of failures of adequate response to the<br /><br>detection of relapses or cardiovascular risk factors. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Satisfaction of participating patients, GPs and oncologists. Psychosocial well<br /><br>being of patients will be assessed with questionnaires (HADS, SF 36 and<br /><br>Distress Thermometer) when visiting their GP.</p><br>